The World Health Organization (WHO) launched C-TAP two years ago to enable developers of medical products against Covid-19 to share their intellectual property and know-how with other manufacturers in order to maximize production capacity and thus enhance global access. What has become of this ambition? And what is needed to unleash the potential of C-TAP, also for future pandemic preparedness and response?
At the event, diverse experts shared their experiences, insights and recommendations regarding C-TAP and/or a future technology sharing mechanism as part of global pandemic preparedness and response.
Speakers (in order of appearance):
- Ella Weggen (moderator), Senior Global Health Advocate at Wemos
- Román Macaya, former Head of Social Security Costa Rica
- Erika Dueñas Loayza, Head of the intellectual property unit at WHO’s division for access to medicines and health products
- Esteban Burrone, Head of Policy at the Medicines Patent Pool
- Felipe Vera, Advisor of the Vice-Minister of Health Chile (replacing Cristóbal Cuadrado, Vice-Minister of Health Chile)
- Jesús Marco, Vice-President for Science and Technology at the Spanish National Research Council
- Irene Bernal, Senior Expert on Health and Social Policies at Salud Por Derecho
- Mark van Passel, Senior Policy Advisor Global Health Security at the Dutch Ministry of Health, Welfare and Sport
- James Love, Director of Knowledge Ecology International
- Ellen ’t Hoen, Director of Medicines Law & Policy
This event was organised by the Covid-19 Innovations for All (CIFA) consortium, consisting of Corporación Innovarte, Health Action International, Knowledge Ecology International, Medicines Law & Policy, the Pharmaceutical Accountability Foundation, and Wemos.
